Morgan Stanley raises Goldman Sachs stock price target to $706 on higher revenue outlook

Morgan Stanley has raised its price target for Goldman Sachs (GS) to $706.00 from $680.00, maintaining an Equalweight rating, driven by a 4% increase in its 2026 earnings per share estimate to $54.33. This upward revision reflects expectations for stronger Markets, Asset & Wealth Management, and Investment Banking revenues, alongside a lower share count, despite projected higher expenses. While GS shares have returned 44% over the past year and trade near their 52-week high, other recent analyst actions have noted a balanced risk/reward profile or fair valuation despite strong earnings.

Analysis

Morgan Stanley has increased its price target on Goldman Sachs (GS) to $706, a 4% lift, while maintaining an Equalweight rating, underscoring a view that the stock is fairly valued. The target revision is underpinned by a 4% increase in the 2026 earnings per share estimate to $54.33, driven by anticipated strength in Markets, Asset & Wealth Management, and Investment Banking revenues, partially offset by higher expenses. This upgrade comes after the stock has already delivered a 44% return over the past year, trading near its 52-week high and slightly above Morgan Stanley's new target. Other analysts echo this cautious sentiment; JMP Securities holds a Market Perform rating, and Citizens JMP recently downgraded the stock to Market Perform, both citing a balanced risk/reward profile at current price levels. Concurrently, Goldman Sachs is actively engaged in capital markets, advising on a potential IPO for Via Transportation and a potential sale of Quicken. The firm also resolved a significant legal overhang by agreeing, with peers, to a $120 million settlement related to the Archegos collapse, which removes a specific litigation risk.

Key Decisions for Investors

• Given that Goldman Sachs is trading near its 52-week high and that multiple analysts rate it as fairly valued, investors should be cautious about initiating new long positions at current levels.
• The strong fundamental outlook and positive earnings revisions may justify a hold strategy for existing investors, but upside appears limited as the new $706 price target is below the current market price.
• Investors should closely monitor revenue performance in the Markets and Asset & Wealth Management divisions in subsequent earnings reports to validate the optimistic forecasts supporting the stock's valuation.
• While the Archegos settlement resolves a specific legal issue, the balanced risk/reward profile highlighted by analysts suggests that further catalysts beyond current expectations are needed to drive significant stock appreciation.